MSH2 and cancer: In addition, LRs accounted for more than 20% of pathogenic variants in BMPR1A, CDKN2A p14ARF, MSH2/EPCAM, PMS2, and RAD51C. The substantial proportion of LRs seen in cancer predisposition genes highlights the need to identify and classify this type of variant accurately for appropriate medical management.